WASHINGTON — The Meals and Drug Administration is launching a program to reward corporations with accelerated drug evaluation and speedy company suggestions, if their actions align with the company’s nationwide well being priorities.
These priorities embody addressing unmet public well being wants or well being crises, beefing up home manufacturing of medication, and delivering extra modern cures, in line with a press launch from the well being division.
The Tuesday announcement strains up with the Trump administration’s broader effort to realize its well being care priorities with out issuing rules. Amongst different steps, it’s attempting to push corporations to decrease drug costs and construct extra factories within the U.S. by threatening dramatic tariffs and tying costs to these paid abroad.
This text is unique to STAT+ subscribers
Unlock this text — plus every day intelligence on Capitol Hill and the life sciences business — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
